Schizophreniform Disorder
Schizophreniform disorder is a type of psychotic illness with symptoms similar to those of schizophrenia, but lasting for less than 6 months. Like schizophrenia, schizophreniform disorder is a type of “psychosis” in which a person cannot tell what is real from what is imagined.
Cluster Number:
Wiki Number: PW196
Diagnosis: Schizophreniform Disorder
US Patients:
World Patients :
Sex Ratio:
Age Onset: M, 18-14; W, 18-3
Brain Area:
Symptoms: On month of schizophrenic events while the schizophrenia diagnosis requires at least 6 months. Start as only 1/5th as many as full.
Progression: The levels of disease and shorter duration are less than full schizophrenia. But 2/3 later develop full schizophrenia.
Causes: genetic and stress-triggers; more likely with other family members with schizophrenia
Medications: antipsychotics
Therapies: individual, family and ocuppational therapies can reduce the impact
Youtube Video: Schizophreniform Disorder
Amazon or Library Book: From Hopelessness to Hopeful: (Schizophreniform Disorder)
Click the book to link or order from Amazon.
Support Group: sczaction-800-493-2084
(Schizophrenia Action Alliance)
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Fahr's disease with neuropsychiatric symptoms and intermittent course: a case reportby Maryam Niksolat on May 17, 2024
Fahr's disease is a rare neurodegenerative disorder with brain calcifications and neuropsychiatric symptoms. It can have variable phenotypic expression and intermittent symptomatology, making diagnosis challenging. In this report, we describe a young female patient presenting with symptoms of psychosis and confusion, which could be indicative of a delirium superimposed on the cerebral vulnerability associated with Fahr's disease. Notably, about two years prior, she experienced multiple episodes...
- International Experience of Implementing Cognitive Remediation for People With Psychotic Disordersby Frances L Dark on May 17, 2024
CONCLUSIONS: CR is an effective intervention for the cognitive impact of schizophrenia. Programs can be implemented in diverse settings globally. Adaptations of CR centering upon the core components of effective CR therapy enhance outcomes and enable programs to integrate into diverse settings.
- Dementia in Rare Genetic Neurodevelopmental Disorders: A Systematic Literature Reviewby Hadassa Kwetsie on May 17, 2024
BACKGROUND AND OBJECTIVES: Knowledge of young-onset Alzheimer disease in adults with Down syndrome has greatly improved clinical care. However, little is known about dementia in rare genetic neurodevelopmental disorders (RGNDs). In this review, a comprehensive overview is provided of reports on dementia and cognitive/adaptive trajectories in adults with RGNDs.
- Prevalence and correlates of depression, anxiety and trauma-like symptoms in Chinese psychiatric patients during the fifth wave of COVID-19 pandemic: a cross-sectional study in Hong Kongby Joe Kwun Nam Chan on May 17, 2024
CONCLUSIONS: Our results affirm increased vulnerability of psychiatric patients toward psychological distress during pandemic. An array of identified correlates facilitates early detection of high-risk psychiatric patients for targeted strategies to minimize pandemic-related negative psychological impact.